Page last updated: 2024-09-03

candoxatrilat and Coronary Disease

candoxatrilat has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alabaster, CT; Barclay, PL; Connell, JM; Dargie, HJ; Dilly, SG; Findlay, IN; Jardine, AG; Lever, AF; Northridge, DB; Samuels, GM	1

Trials

1 trial(s) available for candoxatrilat and Coronary Disease

Article	Year
Effects of UK 69 578: a novel atriopeptidase inhibitor. Lancet (London, England), 1989, Sep-09, Volume: 2, Issue:8663 Topics: Animals; Atrial Natriuretic Factor; Clinical Trials as Topic; Coronary Disease; Cyclohexanecarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug Evaluation, Preclinical; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuresis; Nephrectomy; Neprilysin; Rats; Rats, Inbred Strains; Time Factors	1989

Article

Year

Effects of UK 69 578: a novel atriopeptidase inhibitor.

Lancet (London, England), 1989, Sep-09, Volume: 2, Issue:8663

Topics: Animals; Atrial Natriuretic Factor; Clinical Trials as Topic; Coronary Disease; Cyclohexanecarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug Evaluation, Preclinical; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuresis; Nephrectomy; Neprilysin; Rats; Rats, Inbred Strains; Time Factors

1989